Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Carcinogenesis

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CARCIN/BGM218PMID 17916909
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders

  2012cited by this paper
• Review Androgen Receptor Gene and Hormonal Therapy Failure of Prostate Cancer

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Isothiocyanate E‐4IB induces MAPK activation, delayed cell cycle transition and apoptosis

  2007cited by this paper
• Effect of silibinin on the growth and progression of primary lung tumors in mice.

  2006cited by this paper
• Silymarin and silibinin cause G1 and G2–M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin

  2006cited by this paper
• A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients

  2006cited by this paper
• Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch

  2006cited by this paper
• Mechanisms of action of novel agents for prostate cancer chemoprevention.

  2006cited by this paper
• Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-κB: implications for angioprevention and antiangiogenic therapy

  2005cited by this paper
• The ERK cascade

  2005cited by this paper
• Insulin-like growth factors and neoplasia

  2004cited by this paper
• Silibinin Protects against Photocarcinogenesis via Modulation of Cell Cycle Regulators, Mitogen-Activated Protein Kinases, and Akt Signaling

  2004influential reference
• Prostate cancer prevention by silibinin.

  2004influential reference
• Insulin-like growth factors and neoplasia.

  2004cited by this paper
• Regulation of Apoptosis in Prostate Cancer

  2004cited by this paper
• Tumor angiogenesis: a potential target in cancer control by phytochemicals.

  2003cited by this paper
• Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells

  2003cited by this paper
• Cancer chemoprevention with dietary phytochemicals

  2003cited by this paper
• Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.

  2003cited by this paper
• Correspondence re: Chokkalingam A. et al., Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol. Biomark. Prev., 10: 421-427, 2001.

  2002cited by this paper
• Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.

  2002influential reference
• Silibinin inhibits constitutive and TNFα-induced activation of NF-κB and sensitizes human prostate carcinoma DU145 cells to TNFα-induced apoptosis

  2002cited by this paper
• Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.

  2002cited by this paper
• Phytochemicals as Cell Cycle Modulators A Less Toxic Approach in Halting Human Cancers

  2002cited by this paper
• Chemoprevention strategies for prostate cancer.

  2002cited by this paper
• The development of androgen-independent prostate cancer

  2001cited by this paper
• Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

  2001cited by this paper
• The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy.

  2000cited by this paper
• Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.

  2000cited by this paper
• Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.

  2000cited by this paper
• Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.

  2000cited by this paper
• Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.

  1999cited by this paper
• Chemoprevention of Prostate Cancer: Concepts and Strategies

  1999cited by this paper
• Androgen receptor gene and hormonal therapy failure of prostate cancer.

  1998cited by this paper
• Low p27 expression predicts poor disease-free survival in patients with prostate cancer.

  1998cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism*

  1997cited by this paper
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

  1994cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• Cancer statistics

  1989cited by this paper

• Inhibition of Growth and Survival of Head and Neck Cancer Cells by Silibinin Involves the Down‐Regulation of Erk1/2, AKT and STAT3 Signaling

  2025cites this paper
• miR-24-2 targets Akt and inhibits cell survival, EMT, and tumour growth in triple-negative breast cancer.

  2025cites this paper
• Effects of natural extract interventions in prostate cancer: A systematic review and network meta-analysis.

  2024cites this paper
• Effectiveness of Silymarin, Sulforaphane, Lycopene, Green Tea, Tryptophan, Glutathione, and Escin on Human Health: A Narrative Review

  2023cites this paper
• Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer.

  2022cites this paper
• Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies

  2022cites this paper
• Anti-angiogenic effect of a chemically sulfated polysaccharide from Phellinus ribis by inhibiting VEGF/VEGFR pathway.

  2020cites this paper
• Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance.

  2020cites this paper
• Initial biological evaluations of 18F-KS1, a novel ascorbate derivative to image oxidative stress in cancer

  2019cites this paper
• Mechanisms of anti-prostate cancer by Polyphenols compounds

  2019cites this paper
• Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells

  2018cites this paper
• Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway

  2018cites this paper
• Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator

  2018cites this paper
• O-Aminoalkyl-O-Trimethyl-2,3-Dehydrosilybins: Synthesis and In Vitro Effects Towards Prostate Cancer Cells

  2018cites this paper
• Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.

  2017cites this paper
• Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer.

  2017cites this paper
• 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.

  2017cites this paper
• The Potential of Flavonolignans in Prostate Cancer Management.

  2016cites this paper
• Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - A comprehensive review.

  2016cites this paper
• Flavonoids with Therapeutic Potential in Prostate Cancer.

  2016cites this paper
• Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.

  2016cites this paper
• 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.

  2016cites this paper
• Silibinin induces mitochondrial NOX4-mediated endoplasmic reticulum stress response and its subsequent apoptosis

  2016cites this paper
• Silibinin prevents prostate cancer cell‐mediated differentiation of naïve fibroblasts into cancer‐associated fibroblast phenotype by targeting TGF β2

  2015cites this paper
• Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo

  2015cites this paper
• Silibinin exerts cancer chemopreventive efficacy via targeting prostate cancer cell and cancer-associated fibroblast interaction

  2015cites this paper
• Angioprevention in Colon Cancer from Bench to Bedside

  2015cites this paper
• Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

  2015cites this paper
• Silymarin encapsulated poly(D,L-lactic-co-glycolic acid) nanoparticles: a prospective candidate for prostate cancer therapy.

  2014cites this paper
• Silibinin Induces Cell Death through Reactive Oxygen Species–Dependent Downregulation of Notch-1/ERK/Akt Signaling in Human Breast Cancer Cells

  2014cites this paper
• Cáncer Antiproliferative action of silibinin on human colon adenomatous cancer HT-29 cells

  2014cites this paper
• Anti-proliferative action of silibinin on human colon adenomatous cancer HT-29 cells.

  2014cites this paper
• The strategies to control prostate cancer by chemoprevention approaches.

  2014influential citation
• Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.

  2014cites this paper
• Dietary Polyphenols for Prostate Cancer Therapy

  2014influential citation
• Polyphenol-Mediated In Vivo Cellular Responses during Carcinogenesis

  2014cites this paper
• Methods to Analyze Chemopreventive Effect of Silibinin on Prostate Cancer Biomarkers Protein Expression

  2014cites this paper
• Silibinin induces cell death through ROS-dependent down-regulation of Notch-1/ERK/Akt signaling in human breast cancer cells

  2014cites this paper
• Advances in Prostate Cancer Chemoprevention: A Translational Perspective

  2013cites this paper
• Effect of Flavonoids from Fruits and Vegetables in the Prevention and Treatment of Cancer

  2013cites this paper
• Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer

  2013influential citation
• Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cells.

  2013cites this paper
• Anti-cancer and chemopreventive efficacy of grape seed extract against head and neck squamous cell carcinoma through cellular metabolism

  2013cites this paper
• Silibinin Regulates Gene Expression, Production and Secretion of Mucin from Cultured Airway Epithelial Cells

  2012cites this paper
• ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.

  2012cites this paper
• Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.

  2012cites this paper
• The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors

  2012cites this paper
• Amanita mushroom poisoning , viral hepatitis , toxic and drug induced liver diseases and in diabetic patients (

  2012cites this paper
• ProstaCaid TM inhibits tumor growth in a xenograft model of human prostate cancer

  2012cites this paper
• Effects of Bioactive Compounds from Different Potato Genotypes on Prostate Cancer Development in Athymic Nude Mice

  2012cites this paper
• Novel targets for detection of cancer and their modulation by chemopreventive natural compounds.

  2012cites this paper
• Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR Signaling

  2012cites this paper
• Metabolic and toxicological considerations of botanicals in anticancer therapy

  2012cites this paper
• Inositol hexafosfato e câncer de próstata: a importância do p21/cip1 e p27?Kip1

  2011cites this paper
• Clinical trial update and novel therapeutic approaches for metastatic prostate cancer.

  2011cites this paper
• Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.

  2011cites this paper
• Award Number: W81XWH-07-1-0330 TITLE: Estrogen and the Dietary Phytoestrogen Resveratrol as Regulators of the Rho GTPase Rac in Breast Cancer Metastasis

  2011cites this paper
• Silibinin--a promising new treatment for cancer.

  2010cites this paper
• on Tumorigenesis in A/J Mice

  2010cites this paper
• A study of high‐dose oral silybin‐phytosome followed by prostatectomy in patients with localized prostate cancer

  2010cites this paper
• Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer

  2010cites this paper
• Inhibitory Effect of Silibinin against Azoxymethane-Induced Colon Tumorigenesis in A/J Mice

  2010cites this paper
• Silibinin inhibits human nonsmall cell lung cancer cell growth through cell‐cycle arrest by modulating expression and function of key cell‐cycle regulators

  2010cites this paper
• Defining the pathway to insulin-like growth factor system targeting in cancer.

  2010cites this paper
• Natural polyphenols that display anticancer properties through inhibition of kinase activity.

  2010cites this paper
• Targeting silibinin in the antiproliferative pathway

  2010cites this paper
• The Prostate AStudyofHigh-DoseOral Silybin-Phytosome Followedby Prostatectomyin PatientsWith Localized ProstateCancer

  2010cites this paper
• Silibinin in Skin Health: Efficacy and Mechanism of Action

  2009cites this paper
• Silibinin Suppresses Growth of Human Prostate Carcinoma PC-3 Orthotopic Xenograft via Activation of Extracellular Signal-Regulated Kinase 1/2 and Inhibition of Signal Transducers and Activators of Transcription Signaling

  2009cites this paper
• p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.

  2009cites this paper
• A Novel Class of Cyclin-dependent Kinase Inhibitors Identified by Molecular Docking Act through a Unique Mechanism*

  2009cites this paper
• Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells

  2009cites this paper
• Natural Polyphenols that Display Anticancer Activity through Inhibition of Kinase Activity

  2009cites this paper
• Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols

  2009cites this paper
• Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression

  2009cites this paper
• Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells

  2008influential citation
• Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: Comparison with silymarin and silibinin

  2008influential citation
• Complementary and alternative medicine in men’s health

  2008cites this paper
• New combination therapies with cell-cycle agents.

  2008cites this paper
• Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype

  2008cites this paper
• Cyclin-dependent kinases as tumor initiators and therapeutic targets

  2008cites this paper
• Oligomeric proanthocyanidin complexes (OPC) exert anti‐proliferative and pro‐apoptotic effects on prostate cancer cells

  2008cites this paper
• Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice

  2008cites this paper
• Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells

  2008cites this paper
• In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.

  2005cites this paper
• Silibinin downregulates MMP 2 expression via Jak 2 / STAT 3 pathway and inhibits the migration and invasive potential in MDA ‐ MB ‐ 231 cells

  year unknowncites this paper